shield
Restricted Category Experts Since 2016
shield
Restricted Category Experts Since 2016

Four Peptide Brands.
Four 8 Figure+ Successes.

100% Track Record.

In just 12 months. While other agencies experiment with your budget, we deploy the exact playbook that helped scale Effecty, SkinnyRx, Brello Health, and Prime Peptides past 8 figures. Only accepting 3 brands this quarter.

Access The $500M Peptide PlaybookeastView Case Studies
3.5x
Avg Revenue Growth
90 Days
to $250k/Week
350%
Average ROAS
Peptide Brands Scaled to 8+ Figures
circle $500M+ in revenue managed
effecty-logo
$100M+
skinny logo
$120M+
brello-logo
$95M+
prime-peptides-logo
$110M+
The only agency with exclusive peptide infrastructure and proven compliance systems
Client Success Stories
What Our Clients Say
Real results from peptide brand founders who've achieved 8+ figure growth with Spring Media
review stars

"Spring Media understands the peptide space like no other agency. They took SkinnyRx from $8M to 9 figures in 12 months while navigating all compliance requirements flawlessly."

brand owner 3
Sajad Zalzala
Founder
Skinny Rx
Revenue
Result
$120M+
9 Figures
review stars

"The only agency that truly gets peptide marketing. They built our entire compliant funnel and retention system. We hit 8 figures faster than we thought possible."

brand owner 2
Sam Karl
Co-Founder
Effecty
Revenue
Result
$100M+
8 Figures
review stars

"Their expertise in the regulated peptide space is unmatched. Prime Peptides scaled to 9 figures with their strategic positioning and acquisition strategies. Game-changing partnership."

brand-owner 1
Curtis Miller
CEO
Prime Peptides
Revenue
Result
$110M+
9 Figures
arrow-yellow
5
arrow-green
$500M+
arrow-blue
12 Months
Brands Scaled to 8-9 Figures
Peptide Revenue Generated
To 8-9 Figure Scale
review stars
"The only agency that truly gets peptide marketing. They built our entire compliant funnel and retention system. We hit 8 figures faster than we thought possible."
Sam Karl
Co-Founder
Effecty
Revenue
Result
$100M+
8 Figures
review stars
"Their expertise in the regulated peptide space is unmatched. Prime Peptides scaled to 9 figures with their strategic positioning and acquisition strategies. Game-changing partnership."
Curtis Miller
CEO
Prime Peptides
Revenue
Result
$110M+
9 Figures
review stars
"Spring Media understands the peptide space like no other agency. They took SkinnyRx from $8M to 9 figures in 12 months while navigating all compliance requirements flawlessly."
Sajad Zalzala
Founder
Skinny Rx
Revenue
Result
$120M+
9 Figures
arrow-yellow
5
Brands Scaled to 8-9 Figures
arrow-green
$500M+
Peptide Revenue Generated
arrow-blue
12 Months
To 8-9 Figure Scale
arrow-green
Proven Results
Peptide Brands We've Helped Scale
4 peptide brands scaled to 8+ figures in 12 months. Here's how we navigated the regulated space to achieve exceptional growth.
effecty-image
effecty-logo
Premium Peptides
Scaled from 0 to 8+ figures through strategic peptide-focused Meta and Google campaigns with compliant messaging
Result
Revenue
8 Figures
$100M+ Revenue
skinny-image
skinny logo
Weight Loss Peptides
Built complete retention system and subscription model for GLP-1 peptides, achieving 9-figure revenue
Result
Revenue
9 Figures
$120M+ Revenue
brello-image
brello-logo
Longevity Peptides
CRO optimization and educational content strategy for complex peptide products, reaching 8 figures
Result
Revenue
8 Figures
$95M+ Revenue
primepeptides-image
prime-peptides-logo
Performance Peptides
Full-funnel system for athletic performance peptides with retention focus, scaled to 9 figures
Result
Revenue
9 Figures
$110M+ Revenue
Exclusive
Infrastructure Access
Peptide Specific Payment Processing
Purpose built merchant infrastructure designed for peptide businesses, with stable approvals, higher limits, and long term reliability where traditional processors fall short.
check_circle
Guaranteed beat your current rate
check_circle
48 hour setup time
check_circle
No matchlisting risk
check_circle
Great customer service
Peptide Manufacturing
Direct access to vetted labs and compliant production partners to ensure consistent quality, scalable supply, and operational continuity as you grow.
check_circle
Guaranteed beat your current rate
check_circle
Up to 40% COGS savings
check_circle
Ethical Supply Chains
(we refuse to sell low quality peptides)
check_circle
COA’s provided
Peptide Compliant Customer Retention
Retention systems structured around regulatory safe messaging, lifecycle strategy, and subscription behavior that increase lifetime value without platform risk.
check_circle
Email & SMS automation
check_circle
Subscription Optimization
check_circle
LTV maximization system
check_circle
Direct mail system
check_circle
Customer Service (Phone, Email & AI support)
Peptide Compliant Content Creation
Educational first content engineered to meet platform and regulatory standards while building authority, trust, and long term brand equity.
check_circle
Long form educational assets
check_circle
Regulatory safe messaging frameworks
check_circle
UGC and advertorial formats
check_circle
Landing page and advert compliance
check_circle
Ongoing creative testing pipeline
Peptide Specific Content Creators and Influencers
A curated network of peptide fluent creators who understand the space, communicate responsibly, and attract qualified, high intent audiences.
check_circle
Pre vetted peptide niche creators
check_circle
Scientific and education first positioning
check_circle
Compliant scripts and messaging
check_circle
Performance based partnerships
check_circle
Scalable seeding and ambassador programs
Peptide Compliant Customer Acquisition
Acquisition channels built specifically for restricted categories, combining compliant media buying, diversified traffic sources, and durable scale.
check_circle
Policy aware media buying
check_circle
Account structure and risk management
check_circle
Creative and copy compliance systems
check_circle
Meta, Google, YouTube, Reddit, Taboola, Bing and emerging sources
Internal Peptide Subscription Platform
A proprietary subscription system designed for continuity revenue, flexible billing logic, and full control over customer relationships and data.
check_circle
Custom billing cadences
check_circle
Smart retries and recovery flows
check_circle
Subscription optimization tools
check_circle
Dispute and chargeback management
check_circle
First party data ownership
Private Equity and M&A Advisory for Peptide Business
Strategic guidance, deal structuring, and buyer access to help founders navigate growth, capital events, and exits with institutional confidence.
check_circle
Buy side and sell side advisory
check_circle
Investor and buyer introductions
check_circle
Valuation strategy
check_circle
Deal structuring and diligence support
check_circle
Roll up and consolidation strategy
The Window Is Closing
A $12.5B Market.

One Shot to Lead It.
Eli Lilly acquired Versanis for $1.9B. Novo Nordisk is expanding aggressively. Hims & Hers is disrupting telehealth peptides. The institutional wave is coming—and they'll pay premium multiples for brands with proven systems, clean compliance, and category leadership.
arrow-green
$12.5B
Market Size 2024
Growing 8.3% annually
127%
YoY Search Growth
Mainstream momentum building
15-25x
Exit Multiples
For compliant peptide brands
Why Others Fail
Most Agencies Get Banned
Traditional agencies don't understand peptide compliance. They treat it like supplements—and their campaigns die before they scale.
FDA gray areas & platform compliance
Building trust in nascent category
Balancing growth with regulatory prudence
Spring Media's Edge
We Wrote the Playbook
4 peptide brands. 8-9 figures each. 12 months. 100% success rate.
Proprietary Compliance Framework
Navigate FDA and platform restrictions without killing growth
Proven Systems & Playbooks
4 for 4 brands scaled to 8-9 figures in 12 months
Exit-Ready Positioning
Build for acquisition as pharma giants enter the space
Track Record
100%
Revenue Generated
$500M+
Exit Strategy
Building for Growth.
Positioning for Exit.
When pharma giants need peptide DTC expertise, they look for brands with proven systems, clean compliance, and category leadership. We build you to be that brand.
15-25x
EBITDA Multiples
100%
Exit-Ready
Proprietary Technology
The Spring System™
A three-phase growth architecture built specifically for peptide brands. Compliance-first, AI-powered, and proven across $500M+ in revenue.
PHASE 01
Compliance Intelligence
Proprietary framework for navigating FDA gray areas, platform restrictions, and advertising policies across Meta, Google, and TikTok.
CORE CAPABILITIES
circle
Pre-approved claim database
circle
Real-time policy monitoring
circle
Ad account protection protocols
circle
Compliant creative systems
PHASE 02
Neural Acquisition
AI-powered creative testing engine trained on $500M+ in peptide ad spend, identifying winning angles before human intuition catches up.
CORE CAPABILITIES
circle
Predictive creative scoring
circle
Audience micro-segmentation
circle
Dynamic landing page optimization
circle
Multi-platform orchestration
PHASE 03
Revenue Architecture
End-to-end retention infrastructure that maximizes LTV through subscription psychology, behavioral triggers, and premium positioning.
CORE CAPABILITIES
circle
Subscription conversion systems
circle
Retention automation sequences
circle
LTV optimization modeling
circle
Premium direct mail integration
System Performance
Validated Across $500M+ in Revenue
4
Brands Scaled
90Days
Average Time to 8-Figures
100%
System Success Rate
$500M+
Revenue Generated
This isn't theory. The Spring System™ is the same growth architecture that scaled Effecty, SkinnyRx, Brello Health, and Prime Peptides to 8-9 figures.
Simple Process
From Application To
8-9 Figure Scale
Our proven peptide-focused process that's scaled 4 brands in 12 months
01
Free Strategy Call
30-minute audit of your current funnel and growth blockers
Day 1
02
Custom Growth Plan
We build your tailored Growth Engine roadmap with projected ROI
Week 1
03
Launch & Scale
Deploy campaigns, creative, and retention systems
Week 2-4
04
Optimize & Compound
Continuous testing and scaling to 8-9 figure revenue targets
Ongoing
green-check
90-Day Revenue Growth Guarantee
No growth? We work for free until you do.
ROI Calculator

Calculate Your
Potential Growth

Based on our proven track record scaling 4 peptide brands to 8-9 figures in 12 months
Your Current Monthly Revenue
$2,150,000
$100k
$4.2M
Current Monthly Revenue
$2,150,000
Projected in 6 Months
$7,525,000
Additional Revenue
+$5,375,000
Growth Multiple
3.5x
Get Your Custom Growth Plan east
Free strategy call • No commitment required
* Results based on average client performance. Individual results may vary.
Common Questions
Questions We Get Asked
Direct answers about how we work, what we guarantee, and why we're different
How is Spring Media different from a typical marketing agency?
We are not a marketing agency, we're a full stack growth infrastructure company. While agencies just run ads, we provide the entire operational backbone: exclusive manufacturer partnerships (up to 40% cost savings), peptide-specialized payment processing, whitelisted ad accounts, subscription platforms, and M&A advisory. Most agencies can't access these partnerships. We can.
What if our payment processor gets shut down?
We maintain relationships with multiple high-risk payment processors specifically built for the peptide industry. Platform risk management is core to our service: we have backup systems ready and proactive monitoring to minimize disruptions. Unlike working with generic processors, our partners understand peptide compliance.
Do you guarantee specific revenue or customer numbers?
No, and you should be skeptical of anyone who does. What we guarantee is infrastructure that won't collapse, compliant systems that won't get banned, and data-driven optimization from a playbook that's taken 4 peptide brands to 8-9 figure. Our 100%  success rate speaks for itself:  we've never failed to scale a qualified partner.
What's the minimum to work with Spring Media?
We exclusively work with peptide brands doing $100K - $4.2M in monthly revenue. Below that, you're not ready for our infrastructure. Above that, you likely need a different model. Our sweet spot is brands ready to scale from 7 to 8-9 figures with proper systems in place.
Can you help us position for acquisition or exit?
Yes. M&A advisory is included in our partnership. We've seen the exit landscape; pharma giants like Eli Lily paying $1.9B for Versanis, and 15-25x EBITDA multiples for compliant peptide brands. We position you as an acquisition target from day one, clean compliance, proven systems, category leaderships.
Why do you only take 3 partners per quarter?
Our infrastructure model requires deep integration into your operations; this isn't cookie-cutter agency relationship. Each partnership gets dedicated resources: custom compliance frameworks, exclusive manufacturer introductions, and hands-on strategic guidance. We'd rather do 3 partnerships exceptionally than 30 poorly.
Still have questions? Book a strategy call
Is Spring Media
Right For You?
We work exclusively with premium peptide brands. Here is who we work best with:
blue-check
Perfect Fit
  • Premium peptide brand doing $100k-$4M/month
  • Ready to invest in aggressive peptide market growth
  • Need exclusive infrastructure (manufacturers, payments, content)
  • Looking for a specialized long-term growth partner
  • Willing to test and iterate in regulated space
grey-x
Not a Fit
  • Not a peptide or longevity brand
  • Just starting out (under $50k/month)
  • Looking for quick overnight results
  • Want to maintain full creative control
  • Not ready to scale ad spend aggressively
Check If You Qualify east

Let’s Build Your
Growth Engine

Ready to scale your peptide brand to 8+ figures? Let us talk about your growth goals.

Email Us

rowan@springmediainc.com

Send Email east

Live Chat

Available Mon-Fri, 9am-6pm EST

Start Chateast

Book a Call

30-minute strategy session

Schedule Noweast

Response within 2 hours • Only 3 spots left this quarter
check_circle
No obligation
check_circle
Free funnel audit included
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.